PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933307
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933307
The global intracranial aneurysm market is witnessing steady growth due to the rising prevalence of cerebrovascular diseases, increasing awareness of early diagnosis, and rapid advancements in minimally invasive neurovascular treatment technologies. The market was valued at USD 1.74 billion in 2025 and is projected to grow from USD 1.87 billion in 2026 to USD 2.95 billion by 2034, registering a CAGR of 5.90% during the forecast period. North America dominated the market with a 43.70% share in 2025, supported by strong healthcare infrastructure, active research initiatives, and high adoption of advanced aneurysm treatment devices.
Market Overview
An intracranial or cerebral aneurysm is a balloon-like dilation of blood vessels in the brain caused by weakened vessel walls. If ruptured, it can lead to severe internal bleeding and can be life-threatening. Treatment options include microsurgical clipping and minimally invasive endovascular procedures such as coiling, stenting, and flow diversion. Increasing awareness among patients and healthcare providers regarding these treatment approaches is significantly boosting demand for intracranial aneurysm devices globally.
According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the U.S. live with an unruptured brain aneurysm, highlighting the large patient pool requiring diagnosis and treatment.
Impact of COVID-19
The COVID-19 pandemic negatively affected the intracranial aneurysm market due to reduced elective neurovascular procedures and disruptions in the supply chain of medical devices. A decline in procedure volumes during the pandemic led to slower market growth. However, the gradual resumption of hospital services and delayed neurovascular interventions helped the market regain stability post-pandemic.
Market Trends
A major trend shaping the market is the growing preference for minimally invasive procedures. Traditional craniotomy and clipping methods are increasingly being replaced by endovascular techniques such as coiling and flow diversion, which reduce recovery time and procedural risks. Technological advancements in flow diverters have expanded their use from complex aneurysms to small and medium-sized lesions, driving higher adoption and encouraging innovation among device manufacturers.
Market Growth Drivers
The increasing prevalence of cerebral aneurysms globally is a key driver of market growth. Advanced imaging technologies such as magnetic resonance angiography and 3D angiography have improved early detection rates, increasing the number of patients seeking treatment. Additionally, strong support from public and private organizations for aneurysm research is accelerating innovation. Research grants and long-term clinical studies are enabling the development of next-generation therapeutic devices with improved safety and efficacy.
Countries such as Japan show a higher risk of aneurysm rupture, which has led to early screening programs and increased demand for aneurysm treatment devices.
Restraining Factors
Despite technological progress, misdiagnosis and high treatment costs remain significant challenges. Treating ruptured aneurysms is substantially more expensive than managing unruptured cases. Moreover, limited awareness, lack of standardized diagnostic guidelines, and inadequate healthcare infrastructure in developing regions contribute to delayed diagnosis, restricting broader market penetration.
By product type, aneurysm therapeutic devices dominated the market with a 44.39% share in 2026, driven by high adoption of coils, clips, flow diverters, and intravascular devices. Based on aneurysm type, saccular aneurysms accounted for 90.91% of the market in 2026, as they are the most commonly diagnosed form. By end-user, hospitals led the market with a 72.19% share in 2026, owing to the availability of skilled professionals and advanced neurovascular treatment facilities.
North America generated USD 0.76 billion in 2025, driven by strong awareness programs, early adoption of minimally invasive procedures, and robust R&D activity. Europe followed, supported by EU-funded research initiatives and innovation-driven startups. Asia Pacific is expected to grow at the highest CAGR, due to a high disease burden, expanding healthcare access, and lower surgical costs in countries such as India and China.
Competitive Landscape
The market is highly consolidated, with Stryker, Medtronic, and Terumo Corporation leading globally. These companies are focused on acquisitions, partnerships, and new product launches to strengthen their portfolios. Emerging players are also investing heavily in R&D to establish their presence in the neurovascular devices market.
Conclusion
The global intracranial aneurysm market is poised for consistent growth, expanding from USD 1.74 billion in 2025 to USD 2.95 billion by 2034, driven by rising prevalence of cerebral aneurysms, growing preference for minimally invasive treatments, and continuous technological advancements. While challenges such as misdiagnosis and high treatment costs persist, increasing research funding, improved diagnostic capabilities, and expanding healthcare infrastructure are expected to support sustained market growth throughout the forecast period.
Segmentation By Product Type
By Type
By End-User
By Region